The current financial score of AxoGen Inc is 8.61. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 75.83M, representing a year-over-year increase of 26.22%, while its net profit experienced a year-over-year increase of 229.66%.
The current valuation score of AxoGen Inc is 8.30. Its current P/E ratio is -78.67, which is -91.56% below the recent high of -6.64 and -975.32% above the recent low of -846.01.
The current earnings forecast score of AxoGen Inc is 8.40. The average price target is 59.09, with a high of 65.00 and a low of 56.00.
The current price momentum score of AxoGen Inc is 5.91. Currently, the stock price is trading between the resistance level at 57.14 and the support level at 38.51, making it suitable for range-bound swing trading.
The current institutional shareholding score of AxoGen Inc is 10.00. The latest institutional shareholding proportion is 91.60%, representing a quarter-over-quarter decrease of 6.40%.
The current risk assessment score of AxoGen Inc is 5.24. The company's beta value is 0.94. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.